ARID1A Gene Mutation
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation (NCT05023655) | Prisma Health-Upstate | 2022-01-06 |
| A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer (NCT05226507) | Nuvectis Pharma, Inc. | 2021-12-31 |
Track ARID1A Gene Mutation automatically
Every clearance here is in the API, with alerts when new ones post.